Student Name Western Governors University D031 Advancing Evidence-Based Innovation in Nursing Practice Prof. Name Date Importance of Selecting High-Quality Evidence Sources Selecting reliable and high-quality evidence is fundamental when advocating for disruptive innovations in healthcare. Such evidence provides a scientifically sound basis that validates how an innovation can enhance patient outcomes, improve provider efficiency, and increase overall system effectiveness. Without credible research backing, even the most innovative healthcare solutions may struggle to gain acceptance within clinical practice or organizational policies. Robust evidence plays a key role in supporting change by underpinning evidence-based decision-making and strengthening the legitimacy of new healthcare approaches. Disruptive innovations have become increasingly prevalent in healthcare, aiming to improve workflow efficiency, lessen the burden on providers, and enhance patient satisfaction. Examples include telehealth systems, AI-powered diagnostic tools, and electronic clinical decision support platforms. To effectively justify the adoption of these innovations, decision-makers must depend on research that demonstrates measurable benefits rather than relying on anecdotal reports or personal opinions. Why Are High-Quality Evidence Sources Necessary? Why is it essential to use high-quality evidence sources? These sources offer objective, reliable, and reproducible data that underpin clinical and organizational changes. Peer-reviewed research articles with rigorous methodologies reduce bias and provide findings that can be generalized to wider populations. High-quality evidence answers critical questions about an innovation’s effectiveness, safety, and feasibility by presenting empirical data. Conversely, relying on low-quality evidence or opinion-based articles diminishes the credibility of any argument and risks introducing ineffective or unsafe practices. Evidence that lacks reproducibility or verification does not meet the standards for evidence-based practice. As a result, innovations supported by weak evidence are less likely to receive approval from regulatory agencies, leadership, or clinical stakeholders. How Can High-Quality Evidence Be Identified? How do we determine whether an evidence source is of high quality? A high-quality article is relevant to the clinical question, current, methodologically sound, and free from major bias. Various standardized tools and algorithms assist clinicians and learners in evaluating research rigor. For example, Western Governors University (WGU) offers a structured evidence-leveling algorithm that guides the appraisal of research credibility and strength. The most robust evidence is classified as Level I, which includes comprehensive syntheses of multiple studies such as systematic reviews and meta-analyses. This type of evidence informs clinical guidelines and policy decisions, making it highly valuable when updating standards of care or healthcare policies. Levels of Evidence Commonly Used to Support Guidelines The following table categorizes common levels of evidence in healthcare research, describing each type and its significance in clinical practice: Level of Evidence Type of Source Description Relevance to Practice Level I Systematic reviews, meta-analyses, national practice guidelines Comprehensive synthesis of multiple high-quality studies Strongest support for policy and guideline development Level II Randomized controlled trials (RCTs) Experimental studies with controlled variables High reliability for evaluating interventions Level III Cohort and case-control studies Observational studies examining outcomes Useful when RCTs are not feasible Level IV Case studies and qualitative research Descriptive or exploratory research Provides contextual understanding Level V Expert opinions and anecdotal evidence Subjective perspectives without empirical data Lowest level of evidence How Does High-Quality Evidence Support Innovation Implementation? High-quality evidence is essential for successfully implementing innovations in healthcare. It provides a rational foundation for updating existing guidelines, introducing new technologies, or revising organizational policies. When innovations are supported by strong evidence, stakeholders—including clinicians, administrators, and regulatory bodies—are more likely to trust and invest in these changes. Ultimately, the goal of using high-quality evidence is to ensure healthcare innovations are safe, effective, and consistent with best practices. Evidence-based support not only bolsters the case for innovation but also safeguards patients and organizations against unintended negative consequences. As healthcare continues to evolve, careful selection and critical appraisal of evidence will remain vital to advancing quality, safety, and patient outcomes. References Melnyk, B. M., & Fineout-Overholt, E. (2019). Evidence-based practice in nursing and healthcare: A guide to best practice (4th ed.). Wolters Kluwer. Polit, D. F., & Beck, C. T. (2021). Nursing research: Generating and assessing evidence for nursing practice (11th ed.). Wolters Kluwer. Stillwell, S. B., Fineout-Overholt, E., Melnyk, B. M., & Williamson, K. M. (2010). Evidence-based practice: Step by step. American Journal of Nursing, 110(5), 41–47. https://doi.org/10.1097/01.NAJ.0000372071.24134.7e

Student Name Western Governors University D031 Advancing Evidence-Based Innovation in Nursing Practice Prof. Name Date D031: CPE Schedule & Nurse Innovator Responsibilities Overview CPE Schedule Table What are the required CPE activities and their details? The schedule for the Continuing Professional Education (CPE) activities is designed to support effective time management and ensure timely completion of all course deliverables. Each required activity includes a description of the deliverable, the anticipated completion date, and the estimated time commitment. The table below organizes this information for clarity: Required CPE Activity Deliverable Description Anticipated Completion Date Estimated Time 1a CPE schedule table April 4, 2024 30 minutes 1b Description of nurse innovator roles and responsibilities April 4, 2024 1 hour 1c Three screenshots from GoReact activities April 10, 2024 45 minutes 1d Written reflection summary April 10, 2024 30 minutes 2a Reflection on cohort overview and evidence-leveling tool April 6, 2024 90 minutes 2b Discussion on importance of high-quality evidence April 7, 2024 45 minutes 2c Three screenshots from GoReact activities April 10, 2024 30 minutes 2d Written reflection summary April 10, 2024 30 minutes 3a Description of underlying healthcare practice problem April 11, 2024 90 minutes 3b Identification of disruptive innovation April 13, 2024 90 minutes 3c References for five scholarly articles April 13, 2024 90 minutes 3d Description of evidence search process April 14, 2024 1 hour 3e Three screenshots from GoReact activities April 10, 2024 45 minutes 3f Written reflection summary April 10, 2024 30 minutes This structured approach enables learners to balance their coursework efficiently while maintaining focus on quality deliverables. Nurse Innovator Roles and Responsibilities What is the role and responsibility of a nurse innovator? Nurse innovators hold a pivotal position in advancing healthcare due to their direct involvement with patient care and clinical processes. Their unique vantage point allows them to identify inefficiencies, safety issues, and opportunities for system enhancements. Nurses serve as patient advocates who design and implement novel solutions that improve care quality and patient outcomes. A nurse innovator leverages clinical expertise, critical thinking, and creativity to improve processes, services, and care models. Innovation in nursing frequently stems from the need to simplify workflows, enhance patient comfort, minimize adverse effects, and optimize operational efficiency. These improvements often originate at the bedside, where nurses encounter challenges firsthand (Gerard & Lucia, 2023). Successful nurse innovators demonstrate adaptability, resilience, and openness to learning from setbacks. They cultivate a collaborative and positive environment, fostering collective ownership of change initiatives. Nurse leaders also play a key role by empowering frontline staff and aligning innovation efforts with organizational objectives (Rodrigues da Silva et al., 2023). Nursing innovation can be classified into four main categories: generators, optimizers, implementers, and conceptualizers. Regardless of category, the foundation of sustainable innovation rests on four pillars—context, culture, capability, and collaboration—which collectively support impactful change in healthcare settings. Reflection on Phase 1 Activities What insights were gained from Phase 1 activities? Phase 1 offered deep insights into the concept of nursing innovation and the various roles nurses assume in healthcare transformation. Engaging with innovative literature and learning about different types of nurse innovators enhanced the understanding of how frontline nurses contribute to meaningful change. The activities emphasized that many important innovations arise from efforts to improve everyday clinical practices. This phase heightened appreciation for the nurse’s dual role as both a caregiver and an agent of change. Phase 2: Evidence Appraisal and Cohort Learning How did the cohort overview and evidence-leveling navigation tool assist learning? Two prerecorded cohort sessions were integral to grasping course expectations and developing skills in evidence appraisal. The first cohort provided a comprehensive overview of course phases, deliverables, and resources, including an introduction to disruptive innovation and topic selection guidance. The second cohort concentrated on the Evidence-Leveling Navigation Tool, teaching detailed methods for locating credible scholarly sources. This included navigation of hyperlinks, application of search algorithms, and critical evaluation of source credibility. The emphasis on distinguishing evidence-based research from opinion-based content ensured the integrity of scholarly work. Why is selecting high-quality evidence important? High-quality evidence is crucial in supporting disruptive innovation in healthcare. Peer-reviewed sources provide validated, unbiased information that strengthens clinical decision-making and innovation proposals. Prioritizing literature published within the last five years ensures that the evidence reflects current best practices and standards. Using reputable databases and peer-reviewed journals enhances the credibility of innovations while safeguarding patient safety, improving outcomes, and promoting ethical practice. This approach reduces the risk of adopting ineffective or unsafe interventions. What was learned from the reflection on Phase 2? Reflection on Phase 2 activities deepened understanding of evidence appraisal and scholarly research methodologies. The cohort recordings offered practical guidance on navigating online libraries and applying evidence-leveling tools effectively. The rationale for adhering to a five-year publication guideline reinforced the necessity of current, relevant research in clinical innovation. Phase 3: Identification of Practice Problem and Disruptive Innovation What healthcare practice problem was identified? Pain management on the medical-surgical unit was recognized as a significant challenge. Patients often experienced insufficient pain control due to breakthrough pain episodes, side effects like nausea, or reluctance to use narcotic analgesics over dependency fears. Variability in individual pain tolerance further complicated management strategies. Effective pain control correlated with better recovery outcomes, while poor pain management led to delayed healing and reduced patient satisfaction. This highlighted an urgent need for alternative pain management approaches. What disruptive innovation was introduced to address this problem? A disruptive innovation was developed involving nonpharmacological pain management methods such as aromatherapy, essential oils, guided meditation, and sound therapy. These were applied both as adjuncts for breakthrough pain and as primary options for patients refusing narcotics. This approach empowered patients with greater autonomy in managing their pain and decreased reliance on medications. Additionally, patients experiencing medication-induced nausea benefited from these alternatives, improving comfort and overall recovery. How was the evidence search process conducted? The evidence search was guided by course materials and cohort instructions, utilizing the WGU online library to find peer-reviewed articles published in the last five years.

Student Name Western Governors University D031 Advancing Evidence-Based Innovation in Nursing Practice Prof. Name Date D031: Evidence-Based Innovation Plan for Constipation Management in Hospice Care Management of Constipation in Hospice and Palliative Care Patients Disruptive Innovation in Healthcare Nurses exert a substantial influence on patient outcomes, satisfaction, and overall quality of care across all healthcare environments. Consistent, competent, and responsive nursing practice is directly associated with improved symptom control, patient trust, and perceived quality of life. Consequently, nurses at every professional level—including staff nurses, nurse leaders, and advanced practice nurses—are ethically and professionally obligated to participate in evidence-based innovation. Structured evidence-utilization frameworks such as the Stetler Model and the Iowa Model provide nurses with systematic approaches to identifying clinical problems, appraising evidence, and implementing sustainable practice change (Polit & Beck, 2019). Within hospice and palliative care, the role of nursing innovation is particularly critical. Hospice nurses focus primarily on comfort, symptom relief, and preservation of dignity at the end of life. Many individuals enter hospice care with chronic symptoms that have been inadequately managed due to fragmented healthcare delivery, insufficient patient and caregiver education, or lack of standardized clinical practices. Among these symptoms, constipation remains one of the most frequent and distressing conditions affecting hospice patients, often exacerbating pain, nausea, anxiety, and overall discomfort. The Centers for Medicare & Medicaid Services (CMS) evaluates hospice performance through the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Hospice Survey, which serves as a core component of the Hospice Quality Reporting Program. This survey captures family and patient perceptions of symptom management, including bowel care (Parast et al., 2021). Data consistently reveal that constipation management remains a quality concern. Disruptive innovations emphasizing early identification, prevention, and continuous symptom monitoring present a meaningful opportunity to improve patient comfort and satisfaction while aligning with regulatory expectations. Constipation as a Clinical Problem in Hospice and Palliative Care What is the prevalence of constipation among hospice and palliative care patients, and why does it remain underrecognized? Constipation affects a significant proportion of individuals receiving hospice and palliative services. Research demonstrates that approximately 40% of patients report constipation during initial palliative care evaluations, with prevalence increasing to nearly two-thirds of patients in specialized palliative care settings (McIlfatrick et al., 2019). Despite this high frequency, constipation is often underrecognized due to inconsistent assessment practices, lack of standardized documentation, and competing clinical priorities in end-of-life care. Why does inconsistent assessment contribute to poor symptom control? Inconsistent bowel assessments directly undermine effective symptom management. McIlfatrick et al. (2019) identified substantial variation in how nurses assess bowel function, document findings, and initiate interventions. Both pharmacologic and nonpharmacologic strategies were frequently delayed or omitted, leading to prolonged patient discomfort and avoidable reductions in quality of life. Without standardized assessment tools, early warning signs are often missed, resulting in reactive rather than preventive care. Implementing uniform bowel assessment instruments integrated into electronic health records, supported by digital tracking and evidence-based treatment algorithms, would enable proactive symptom management. This approach supports hospice principles of comfort, dignity, and patient-centered care while empowering caregivers to participate in symptom monitoring. Existing Disruptive Innovations Supporting Symptom Management Healthcare innovation has increasingly leveraged technology to improve safety, efficiency, and quality of care. One well-established example is the electronic medication administration record (eMAR). eMAR systems have demonstrated effectiveness in reducing medication errors, enhancing documentation accuracy, and enabling real-time interdisciplinary communication (Covetus Technologies Pvt Ltd., 2020). Within hospice care, eMAR supports timely initiation and modification of bowel regimens, ensuring continuity and accountability among team members. Telehealth represents another transformative innovation. Virtual platforms such as Zoom have proven effective across multiple clinical domains, including mental health, nutrition counseling, dermatology, and chronic disease management (Siwicki, 2021). During the COVID-19 pandemic, telehealth ensured continuity of care while reducing infection risks. In hospice settings, telehealth allows clinicians to assess symptoms, educate caregivers, and adjust care plans without requiring in-person visits, thereby expanding access and responsiveness. Nurse Innovator Role in Hospice Care How can nurses act as innovators within hospice settings? Nursing innovation begins with recognition of practice gaps and a willingness to challenge ineffective or outdated processes. Nurses engage in daily innovation through clinical judgment, problem-solving, and adaptation to patient needs. At the graduate and advanced practice level, nurse innovators function as clinician-scientists, system leaders, and change agents who integrate research evidence, clinical expertise, and organizational priorities to improve care delivery (Johnson & Johnson, n.d.). In hospice care, the nurse scientist role is especially impactful. Advanced practice nurses can design and evaluate standardized bowel assessment tools, integrate treatment algorithms into eMAR systems, and analyze outcomes data. Evidence suggests that innovative nursing practices positively influence patient outcomes, staff efficiency, and organizational performance (Kirby et al., 2007). Using Big Data for Innovation Big data refers to the collection and analysis of extensive datasets to identify patterns, relationships, and outcomes that inform clinical and administrative decision-making. In healthcare, big data supports quality improvement, population health management, and evidence-based policy development. For hospice organizations, data derived from electronic health records, medication systems, and patient-reported outcomes can reveal trends related to constipation prevalence, intervention effectiveness, and satisfaction scores. What are the advantages of big data in hospice care? One major advantage is the ability to evaluate relationships between symptom burden, social determinants of health, and care outcomes. These insights can guide targeted interventions, resource allocation, and protocol refinement (Leon-Sanz, 2019). Aggregated bowel assessment data, for example, can be used to identify high-risk populations and standardize best practices. What are the risks associated with big data use? Risks include breaches of confidentiality, unauthorized secondary use of data, and erosion of patient autonomy. Ethical use of big data requires informed consent, robust data governance, and adherence to privacy regulations (Leon-Sanz, 2019). Ethical Use of Big Data Ethical considerations are foundational to healthcare innovation. The American Nurses Association Code of Ethics emphasizes nurses’ responsibility to advance practice while protecting patient rights, privacy, and autonomy (American Nurses Association [ANA], 2017). Although big data can deepen understanding of disease trajectories and care disparities, transparency must

Student Name Western Governors University D031 Advancing Evidence-Based Innovation in Nursing Practice Prof. Name Date Course and Portfolio Overview This MSN Core E-Portfolio presents a comprehensive documentation of the Clinical Practice Experience (CPE) activities required for the course D031: Advancing Evidence-Based Innovation in Nursing Practice. It is designed to showcase a progressive learning journey through multiple phases that integrate evidence-based practice, innovation, and reflective professional development. Each phase includes specific written deliverables, reflections, and supporting artifacts that align with the course outcomes and the requirements for the CPE Record. The portfolio reflects the continuous advancement of nursing knowledge and skills toward improving healthcare outcomes. Phase 1: Required CPE Activities and Timeline The initial phase establishes a clear and structured timeline for completing essential CPE activities, which facilitates effective time management and ensures steady progress. The table below details the activities, their descriptions, anticipated completion dates, and the estimated time required for each task. CPE Activity Description Anticipated Completion Date Estimated Time 1a CPE Schedule Table 08/01/2024 30 minutes 1b Role and Responsibilities of a Nurse Innovator 08/02/2024 1.5 hours 1c GoReact Screenshots (3) 08/15/2024 1 hour 1d Phase 1 Reflection Summary 08/15/2024 30 minutes Role and Responsibilities of a Nurse Innovator What is the role of a nurse innovator in healthcare? A nurse innovator acts as a transformative force within healthcare systems by combining clinical expertise with critical thinking and creative problem-solving to enhance patient outcomes and operational workflows. These professionals identify gaps in care delivery, inefficiencies, and emerging patient needs and then develop and implement novel solutions to these challenges. Their role often intersects with nursing practice, informatics, technology, and organizational leadership. What traits characterize nurse innovators? Nurse innovators are known for their adaptability and willingness to challenge established practices. They typically exhibit a lower risk aversion compared to their peers and actively engage in behaviors that foster innovation, such as piloting new technologies, redesigning care models, and collaborating across disciplines (Leary et al., 2024). Core duties include evaluating evidence, spearheading change initiatives, supporting the integration of digital health tools, and measuring outcomes to ensure sustainable and patient-centered improvements. How important is collaboration in the nurse innovator role? Collaboration is fundamental to the success of nurse innovators. They work closely with healthcare administrators, IT specialists, engineers, and frontline clinicians to ensure innovations are feasible, scalable, and aligned with organizational goals. Additionally, they advocate for policies and educational programs that embed innovation competencies within nursing education, preparing future nurses to act as change agents and sustain professional growth (Cusson et al., 2020). By promoting a culture of inquiry and continuous improvement, nurse innovators contribute to creating safer, more efficient, and equitable healthcare systems. Their leadership enhances patient outcomes, nurse satisfaction, and professional development. Phase 1 Reflection Summary What were the key learnings from Phase 1? Phase 1 underscored the vital role nurses play as innovators within healthcare. It highlighted how frontline nurses are uniquely positioned to identify system inefficiencies and opportunities for improvement. Learning about the attributes of effective nurse innovators reinforced that innovation extends beyond formal leadership roles and is embedded in daily nursing practice. Reflecting on personal experiences revealed many instances where innovative thinking was already applied, often unconsciously. This phase emphasized the importance of deliberately cultivating innovation skills through education and practice to drive ongoing advancements in healthcare delivery. Phase 2: Evidence Appraisal and Scholarly Resources What role did the Overview Cohort and Evidence Leveling Navigation Tool play in this phase? The Overview Cohort provided crucial orientation to course expectations and introduced key resources for completing CPE activities successfully. It clarified the timing and application of the Evidence Leveling Navigation Tool during the appraisal of scholarly literature. How does the Evidence Leveling Navigation Tool support evidence appraisal? This tool offers a structured, stepwise approach to evaluating the quality, relevance, and applicability of research. Its consistent use increased confidence in critically assessing scholarly articles and reinforced the understanding that evidence across various levels can contribute meaningfully to clinical decision-making when appropriately contextualized. Why is selecting high-quality evidence essential for supporting disruptive innovation? Utilizing high-quality, peer-reviewed evidence ensures that innovations are grounded in scientifically validated methodologies and findings. This lends credibility, facilitates stakeholder support, and informs decision-making during the implementation of new care models. Reliable evidence is crucial when introducing disruptive innovations, as these often challenge established workflows and professional norms. Scholarly literature helps identify risks, ethical concerns, and barriers, while demonstrating effectiveness and patient safety. Moreover, evidence-based justification is often necessary for obtaining organizational approval, funding, and sustainability. Phase 2 Reflection Summary What insights were gained during Phase 2? Phase 2 enhanced the understanding that credible, rigorously evaluated research underpins successful innovation. Learning to systematically assess and level evidence improved the ability to differentiate between high-impact studies and less applicable sources. These competencies are vital for future academic work and clinical practice, particularly when proposing or evaluating innovative solutions for complex healthcare challenges. Phase 3: Practice Problem and Disruptive Innovation What are the underlying issues contributing to the identified healthcare practice problem? Healthcare systems face escalating challenges such as increased patient acuity, workforce shortages, and growing technological demands. Bedside nurses must manage patients with complex conditions while handling documentation and adapting to new clinical technologies. High patient-to-nurse ratios contribute to fatigue, burnout, and greater risks for adverse events. Variations in clinical experience among nurses add complexity, as novices or those transitioning to new specialties may lack immediate mentorship or guidance. Additionally, the rapid pace of technological advancement demands continuous learning, which is difficult amid heavy workloads. These factors collectively create a critical need for innovative solutions that support bedside nurses without adding staffing burdens. How can disruptive innovation improve healthcare outcomes? One promising disruptive innovation is the implementation of a virtual resource nurse. This model uses telehealth technology to provide bedside nurses with immediate access to experienced nursing support for clinical decision-making, patient education, documentation help, and care coordination. By shifting certain cognitive and administrative tasks to a virtual nurse, bedside clinicians can focus more effectively on direct

Student Name Western Governors University D031 Advancing Evidence-Based Innovation in Nursing Practice Prof. Name Date Innovation Proposal Scholarly Examples of Disruptive Innovations that Improved Healthcare Disruptive innovations have reshaped healthcare delivery by enhancing accessibility, efficiency, and patient outcomes. One notable innovation is telehealth, which allows patients to access medical care remotely. Telehealth has broadened healthcare access by enabling providers to evaluate, diagnose, and manage patients without requiring physical visits (Haleem et al., 2021). This method is especially beneficial for follow-up care, chronic disease management, and mental health services where direct physical interaction may not be necessary. Telehealth also improves patient convenience and reduces costs. Patients can avoid time off work, transportation issues, and childcare arrangements. From a public health standpoint, telehealth minimizes infection risks for immunocompromised patients by decreasing their exposure to crowded clinical environments. Additionally, it benefits patients with transportation barriers by ensuring continuous care access. Healthcare providers gain from telehealth through improved interdisciplinary collaboration via real-time access to patient data such as medical records, imaging, labs, and medications, which accelerates clinical decision-making (Haleem et al., 2021). Another transformative innovation is robotic-assisted surgery, which has enhanced surgical precision and patient safety. Introduced in 1985 with the first stereotactic brain biopsy at Stanford University, robotic surgery has since been adopted in many surgical fields (National Institutes of Health, n.d.). This technology provides greater stability, precise instrument control, smaller incisions, and better visualization, leading to reduced blood loss, less postoperative pain, faster recovery, and improved quality of life (Tan et al., 2016). Surgeons benefit from decreased physical strain and consistent performance, even during complex procedures. How Does the Nurse Innovator Demonstrate a Role in the Conceptual Model? Nurse innovators are essential in managing the healing environment by addressing social, cultural, economic, and ethical factors that affect patient care. Innovation within nursing aligns with leadership, advocacy, and evidence-based practice according to the nursing conceptual model (Western Governors University, 2021). For instance, a nurse manager at a cardiac step-down unit identified communication barriers due to limited medical interpreter availability for patients with limited English proficiency. This gap posed risks to safety and timely care. The nurse manager conducted a budget analysis and allocated funds to purchase tablets with multilingual translation software. To optimize usage, devices were assigned to key processes like admissions and discharges. The nurse manager presented evidence-based research demonstrating how translation technology improves communication, reduces errors, and boosts patient satisfaction, leading leadership to approve additional tablets. This resulted in better patient safety, higher satisfaction scores, and increased staff morale due to improved tools for care delivery. What Are the Benefits and Challenges of Using Big Data for Innovation? Benefits Big data analytics plays a crucial role in healthcare innovation by analyzing information gathered from mobile health apps, wearables, and electronic health records. These datasets help providers identify behavioral trends, environmental factors, and physiological changes linked to disease onset (Price & Cohen, 2019). By evaluating large volumes of data, healthcare systems can detect high-risk patients earlier and tailor individualized care plans. Personalized interventions reduce unnecessary treatments, enhance outcomes, and lower costs. Big data also supports population health by revealing trends that guide prevention strategies and policymaking. Challenges Despite its advantages, big data presents significant privacy and security concerns. While HIPAA protects traditional healthcare data, it does not fully cover data from smartphones, wearables, online health searches, or consumer apps, leaving gaps that increase risks of unauthorized use or breaches (Price & Cohen, 2019). Voluntary privacy measures by tech companies are inconsistent, raising ethical issues. Healthcare professionals must advocate for stronger regulations and transparent governance of patient data. How Does the ANA Code of Ethics Guide the Ethical Use of Big Data? The American Nurses Association (ANA) stresses that ethical principles must guide big data and artificial intelligence integration in healthcare. Nurses remain accountable for clinical decisions despite technology involvement, which should support, not replace, professional judgment (ANA Center for Ethics and Human Rights, 2022). Ethical practice involves safeguarding patient privacy, ensuring informed consent, and promoting equitable access to technology. Nurses must understand data collection, storage, and usage processes and communicate this clearly to patients. They should assist patients in navigating digital consent forms and advocate for technology that upholds human rights and reduces health disparities (ANA Center for Ethics and Human Rights, 2022). How Does New Technology Support Innovation? Computerized Physician Order Entry (CPOE) systems were developed to enhance medication safety and prescribing accuracy by enabling electronic orders for medications, labs, procedures, and referrals (Alotaibi & Federico, 2019). Often integrated with Clinical Decision Support (CDS), CPOE provides real-time alerts about allergies, drug interactions, abnormal labs, and evidence-based treatment options. The synergy of CPOE and CDS reduces clinical errors and improves workflow efficiency. For example, Jackson Madison County General Hospital implemented Cerner CPOE, which accelerated diagnostic testing and medication verification. Emergency chest x-rays were completed in one-third of the previous time, and pharmacy order verification dropped from one hour to 15 minutes, demonstrating clear operational gains (West Tennessee Healthcare, n.d.). What is the Proposed Disruptive Innovation to Improve Healthcare Outcomes? The innovation proposed is a wearable infrasensor wristband capable of detecting early signs of myocardial infarction within minutes. Using infrared light, it senses cardiac biomarkers like troponin I through the wrist’s thin skin (University of Wisconsin School of Medicine, 2023). The device processes data with an algorithm identifying cardiac injury patterns. When abnormal biomarker levels are detected, the wristband automatically alerts emergency services, even if the wearer is unresponsive. Besides acute event detection, it can identify high-risk individuals for early intervention and prevention. Given that heart attacks rank as the second leading global cause of death (World Health Organization, 2021), this device holds significant potential to improve survival rates and minimize long-term cardiac damage. What is the Description of the Proposed Healthcare Organization? The wristband would be implemented in an assisted living facility catering to adults aged 50 and older. Many residents have multiple cardiovascular risk factors, such as hypertension, diabetes, hyperlipidemia, obesity, smoking history, sedentary lifestyle, and genetics. Routine cardiac testing like EKGs and labs